Policy / European Union
EU Agency Approves Dengue Vaccine for Use Outside Europe
The European Medicines Agency has issued a positive opinion on the Dengue Tetravalent Vaccine (Live, Attenuated) created by Takeda for use outside the EU, highlighting its effectiveness in preventing severe dengue disease in children and adolescents.
Updated
Affected: Workers, Local governments
European Union
08 May 2026